Alps Group Inc (ALPS) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of Alps Group Inc and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALPS
Alps Group Inc
$0.40HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
PDSB
PDS Biotechnology Corporation
$1.20HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALPS vs PDSB
growth of $100 · dividends reinvested · last 1yALPS -96.7% (-96.7%/yr)PDSB +30.5% (+30.5%/yr)PDSB compounded faster over this window
Log scale — wide-divergence pair
ALPS PDSB
ALPS vs PDSB: by the numbers
- •PDSB is the larger company ($67M vs $67M market cap).
- •Both run net losses; PDSB's is the smaller (0.00% vs -41.36% net margin).
Metrics side by side
Profitability
| Metric | ALPS | PDSB |
|---|---|---|
| Gross margin | 32.09% | 0.00% |
| Operating margin | -69.62% | 0.00% |
| Net margin | -41.36% | 0.00% |
| ROIC | N/A | -3699.99% |
Growth (annualized)
| Metric | ALPS | PDSB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -39.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.